Trade Agreement: Agreement on Internal Trade (AIT)
Tendering Procedures: Generally only one firm has been invited to bid
Non-Competitive Procurement Strategy: Protection of Human, Animal, or Plant Life or Health
Comprehensive Land Claim Agreement: No
Vendor Name and Address:
MERCK CANADA INC.
16750 Trans-Canada Hwy
Kirkland (Montreal) Quebec
Canada
H9H4M7
Nature of Requirements:
Definition of Requirement:
Canada proposes to establish a contract with Merck Canada on behalf of the Federal/Provincial/Territorial (F/P/T) Group Purchasing Program for Dr
ugs and Vaccines. The contract is to supply Pneumococcal Polysaccharide
vaccine, on an as and when requested basis to the federal/provincial/territorial (F/P/T) jurisdictions.
Quantities:
The estimated requirement is 527,000 doses for firm year.
Contract Period:
April 1, 2016 to March 31, 2017, with an option to extend the contract period for two additional one-year periods.
Delivery:
Will be on an as-and-when requested basis.
Trade Agreements:
The provisions of the World Trade Organization-Agreement on Government Procurement (WTO-AGP), North AmericanFree Trade Agreement (NAFTA), Canada-Chile Free Trade Agreement (CCFTA) and Canada-Columbia Free Trad
e Agreement Canada- Peru Free Trade (FTA) are not applicable for
reasons connected with the protection of human life and health (see NAFTA article 1018 para. 2 (a) and (b); WTO-AGP article XXIII (2); CC
FTA Article Kbis 16-2(b); and FTA article 1402 para. 2(b) ), and
because of the absence of regulatory harmonization between Canada and the other signatory countries to the WTO, NAFTA CCFTA , and FTA . This requirement is subject to the Agreement on Internal Trade (AIT).
Canada and PWGSC as Agent:
This requirement is for the Federal/Provincial/Territorial (F/P/T)
Group Purchasing Program for Drugs and Vaccines. Canada is acting as a purchasing agent for Provincial and/or Territorial Governments.
Limited Tendering Reason:
It is intended to negotiate directly with Merck Canada Inc. as they are
the only known source of supply licensed by Health Canada’s Biologics and Genetic Therapies Directorate (BGTD) to supply in Canada.
Delivery Date: 01/04/2016
You are hereby notified that the government intends to negotiate with one firm only as identified above. Should you have any questions concerning this requirement, contact the contracting officer identified above.
An Advance Contract Award Notice (ACAN) allows departments and agencies to post a notice, for no less than fifteen (15) calendar days, indicating to the supplier community that it intends to award a good, service or construction contract to a pre-identified contractor. If no other supplier submits, on or before the closing date, a Statement of Capabilities that meets the requirements set out in the ACAN, the contracting authority may then proceed with the award. However, should a Statement of Capabilities be found to meet the requirements set out in the ACAN, then the contracting authority will proceed to a full tendering process.
Suppliers who consider themselves fully qualified and available to provide the services/goods described herein, may submit a statement of capabilities in writing to the contact person identified in this Notice on or before the closing date of this Notice. The statement of capabilities must clearly demonstrate how the supplier meets the advertised requirements.
The PWGSC file number, the contracting officer's name and the closing date of the ACAN must appear on the outside of the envelope in block letters or, in the case of a facsimile transmission, on the covering page.
The Crown retains the right to negotiate with suppliers on any procurement.
Documents may be submitted in either official language of Canada.
